From With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray:

Nessan Bermingham, CEO of Intellia and venture partner at Atlas Venture

Nessan Bermingham, CEO of Intellia and venture partner at Atlas Venture—

Nessan Bermingham, CEO of Intellia and venture partner at Atlas Venture

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences Boston: Special Report
Biopharma's Future in Digital Health

Sponsored · Webinar
July 21 – The Need for Manufacturing Execution Systems (MES) in Cell and Gene Therapy
A discussion on business drivers, technical considerations, special requirements of cell and gene product manufacturing & digitization strategy
Global OT/IT Quality Services

From Our Editors · Podcast
Xcelerating Life Sciences Boston: The Highlights Podcast
Learn what's fueling Boston's biotech and digital health investment and partnership opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!